Pharmacokinetics, Safety and Tolerability of Chiglitazar, A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Pan-Agonist, in Healthy Chinese Volunteers: A Phase I Study - Concepedia

Concepedia

Publication | Closed Access

Pharmacokinetics, Safety and Tolerability of Chiglitazar, A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Pan-Agonist, in Healthy Chinese Volunteers: A Phase I Study

25

Citations

13

References

2019

Year

Hongrong Xu, Jinwen Zhang, Wei‐Li Chen, Zhiqiang Ning, Xuening Li

Clinical Drug Investigation

Pharmacological StudyHealthy Chinese VolunteersPharmacologyPharmacological AgentPharmacotherapyMedicine

References

	Year	Citations

Page 1